is golo a glp-1 drug glp 1 Glucagon-like peptide-1 What science reveals about Golo

Survodutide also reduced waist circumference, an indicator of metabolic health.

Unlike FDA-approved medications (e.g., Wegovy, Ozempic, Zepbound), compounded alternatives lack agency review for safety, quality, and efficacy

PlexusDx provides access to compounded semaglutide starting at $149/month through licensed pharmacies

Discover how Retatrutide works through its triple-pathway mechanism (GLP-1, GIP, glucagon), how it affects metabolism, and when results may begin.

Not a fit for compounded GLP-1? You may still qualify for our Microdosing program, a lower dose option designed for patients outside the standard BMI range

The success of these agents in preclinical models and clinical trials suggests a promising future for multiagonists in the treatment of metabolic diseases, with the most recent glucose-dependent insulinotropic peptide receptor:glucagon-like peptide 1 receptor:glucagon receptor (GIPR:GLP-1R:GCGR) triagonists rivaling the efficacy of bariatric surgery